Recombinant CCN2 (Pamrevlumab Biosimilar) antibody

Catalog No. ABIN7581275

This anti-CCN2 (Pamrevlumab Biosimilar) antibody is a Human Monoclonal antibody detecting CCN2 (Pamrevlumab Biosimilar) in FACS, ELISA, BLI, Func and SPR. Suitable for Human.

Quick Overview for Recombinant CCN2 (Pamrevlumab Biosimilar) antibody (ABIN7581275)

Target: CCN2 (Pamrevlumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCN2 (Pamrevlumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CCN2 (Pamrevlumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CCN2 / CTGF Reference Antibody (pamrevlumab)

Characteristics: Anti-CCN2 / CTGF Reference Antibody (pamrevlumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Conditions: Idiopathic pulmonary fibrosis Pancreatic Cancer

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CCN2 (Pamrevlumab Biosimilar)

Target: CCN2 (Pamrevlumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CCN2

Molecular Weight: 145.5 kDa

UniProt: P29279